Pascal Crépey

1.5k total citations
62 papers, 751 citations indexed

About

Pascal Crépey is a scholar working on Epidemiology, Modeling and Simulation and Infectious Diseases. According to data from OpenAlex, Pascal Crépey has authored 62 papers receiving a total of 751 indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Epidemiology, 29 papers in Modeling and Simulation and 17 papers in Infectious Diseases. Recurrent topics in Pascal Crépey's work include COVID-19 epidemiological studies (29 papers), Influenza Virus Research Studies (27 papers) and Vaccine Coverage and Hesitancy (14 papers). Pascal Crépey is often cited by papers focused on COVID-19 epidemiological studies (29 papers), Influenza Virus Research Studies (27 papers) and Vaccine Coverage and Hesitancy (14 papers). Pascal Crépey collaborates with scholars based in France, United States and United Kingdom. Pascal Crépey's co-authors include Marc Barthélemy, Maarten J. Postma, Fabián P. Alvarez, Pieter T. de Boer, Richard Pitman, Laura Temime, Narimane Nekkab, Pascal Astagneau, Avner Bar‐Hen and Laurent Coudeville and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and PLoS ONE.

In The Last Decade

Pascal Crépey

56 papers receiving 732 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pascal Crépey France 17 422 237 212 176 62 62 751
Gillian Lim Canada 14 464 1.1× 197 0.8× 269 1.3× 227 1.3× 51 0.8× 22 866
Nele Goeyvaerts Belgium 13 379 0.9× 463 2.0× 168 0.8× 104 0.6× 13 0.2× 27 712
John Edmunds United Kingdom 11 428 1.0× 198 0.8× 163 0.8× 84 0.5× 88 1.4× 16 820
Frederik Verelst Belgium 13 192 0.5× 394 1.7× 202 1.0× 227 1.3× 13 0.2× 26 797
Patrick K. Munywoki Kenya 21 927 2.2× 148 0.6× 407 1.9× 52 0.3× 15 0.2× 49 1.2k
Lilith K. Whittles United Kingdom 12 111 0.3× 153 0.6× 190 0.9× 87 0.5× 134 2.2× 26 496
Ashley Fowlkes United States 20 1.1k 2.7× 247 1.0× 743 3.5× 219 1.2× 18 0.3× 39 1.8k
Caroline Guerrisi France 13 266 0.6× 216 0.9× 146 0.7× 78 0.4× 9 0.1× 29 565
Alessandra Løchen United Kingdom 11 224 0.5× 127 0.5× 245 1.2× 63 0.4× 60 1.0× 18 613
Ngai Sze Wong Hong Kong 18 521 1.2× 179 0.8× 555 2.6× 79 0.4× 79 1.3× 108 993

Countries citing papers authored by Pascal Crépey

Since Specialization
Citations

This map shows the geographic impact of Pascal Crépey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pascal Crépey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pascal Crépey more than expected).

Fields of papers citing papers by Pascal Crépey

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pascal Crépey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pascal Crépey. The network helps show where Pascal Crépey may publish in the future.

Co-authorship network of co-authors of Pascal Crépey

This figure shows the co-authorship network connecting the top 25 collaborators of Pascal Crépey. A scholar is included among the top collaborators of Pascal Crépey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pascal Crépey. Pascal Crépey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yang, Jingyan, Jennifer L. Nguyen, Hannah R. Volkman, et al.. (2025). Quantifying all-cause healthcare resource utilization and costs of children with mild-to-moderate long COVID in France. Journal of Medical Economics. 28(1). 1002–1013. 1 indexed citations
2.
3.
Alvarez, Fabián P., F. Bianic, Hélène Bricout, et al.. (2024). Cost-effectiveness and public health impact of using high dose quadrivalent influenza vaccine in the French older adults population. Journal of Medical Economics. 27(1). 1300–1307. 1 indexed citations
4.
5.
Paget, John, et al.. (2022). Preparing for the upcoming 2022/23 influenza season: A modelling study of the susceptible population in Australia, France, Germany, Italy, Spain and the United Kingdom. Influenza and Other Respiratory Viruses. 17(1). e13091–e13091. 4 indexed citations
6.
Lemaître, Magali, Fabrice Carrat, Pascal Crépey, et al.. (2022). Estimating the burden of influenza‐related and associated hospitalizations and deaths in France: An eight‐season data study, 2010–2018. Influenza and Other Respiratory Viruses. 16(4). 717–725. 25 indexed citations
7.
Paireau, Juliette, Alessio Andronico, Nathanaël Hozé, et al.. (2022). An ensemble model based on early predictors to forecast COVID-19 health care demand in France. Proceedings of the National Academy of Sciences. 119(18). e2103302119–e2103302119. 25 indexed citations
8.
Oliosi, Emma, et al.. (2022). A cross-sectional study on infectious health risks regarding freshwater sports practice in Brittany, France. Journal of Water and Health. 20(2). 356–368. 3 indexed citations
9.
Puig‐Barberà, Joan, George Kassianos, Philippe Vanhems, et al.. (2021). A comparison of coronavirus disease 2019 and seasonal influenza surveillance in five European countries: France, Germany, Italy, Spain and the United Kingdom. Influenza and Other Respiratory Viruses. 16(3). 417–428. 11 indexed citations
10.
Temime, Laura, Marie‐Paule Gustin, Audrey Duval, et al.. (2020). A Conceptual Discussion About the Basic Reproduction Number of Severe Acute Respiratory Syndrome Coronavirus 2 in Healthcare Settings. Clinical Infectious Diseases. 72(1). 141–143. 26 indexed citations
11.
Crépey, Pascal, Javier Díez‐Domingo, Raúl Ortíz de Lejarazu, et al.. (2020). From trivalent to quadrivalent influenza vaccines: Public health and economic burden for different immunization strategies in Spain. PLoS ONE. 15(5). e0233526–e0233526. 16 indexed citations
12.
13.
14.
Crépey, Pascal, et al.. (2018). Compartmental models for seasonal hyperendemic bacterial meningitis in the African meningitis belt. Epidemiology and Infection. 147. e14–e14. 11 indexed citations
15.
Elias, Christelle, Anna Fournier, Anca Vasiliù, et al.. (2017). Seasonal influenza vaccination coverage and its determinants among nursing homes personnel in western France. BMC Public Health. 17(1). 634–634. 17 indexed citations
16.
Boer, Pieter T. de, et al.. (2016). Cost-Effectiveness of Quadrivalent versus Trivalent Influenza Vaccine in the United States. Value in Health. 19(8). 964–975. 28 indexed citations
17.
Crépey, Pascal, Pieter T. de Boer, Maarten J. Postma, & Richard Pitman. (2015). Retrospective public health impact of a quadrivalent influenza vaccine in the United States. Influenza and Other Respiratory Viruses. 9(S1). 39–46. 36 indexed citations
18.
Crépey, Pascal, Alexia Kieffer, Nicolas Salez, et al.. (2014). Determinants of individuals’ risks to 2009 pandemic influenza virus infection at household level amongst Djibouti city residents - A CoPanFlu cross-sectional study. Virology Journal. 11(1). 13–13. 7 indexed citations
19.
Mueller, Judith E., et al.. (2014). Drug sales data analysis for outbreak detection of infectious diseases: a systematic literature review. BMC Infectious Diseases. 14(1). 604–604. 24 indexed citations
20.
Crépey, Pascal, et al.. (2013). Potential Impact of Influenza A/H1N1 Pandemic and Hand-Gels on Acute Diarrhea Epidemic in France. PLoS ONE. 8(10). e75226–e75226. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gillian Lim Breakdown of academic impact, for papers by Nele Goeyvaerts Breakdown of academic impact, for papers by John Edmunds Breakdown of academic impact, for papers by Frederik Verelst Breakdown of academic impact, for papers by Patrick K. Munywoki Breakdown of academic impact, for papers by Lilith K. Whittles Breakdown of academic impact, for papers by Ashley Fowlkes Breakdown of academic impact, for papers by Caroline Guerrisi Breakdown of academic impact, for papers by Alessandra Løchen Breakdown of academic impact, for papers by Ngai Sze Wong
Rankless by CCL
2026